To ensure the integrity and quality of raw data collected for CTL clients, the CTL GLP Laboratory abides by United States Food & Drug Administration (US FDA) Regulations for Good Laboratory Practices (GLP) including:
• [21 CFR Part 58] Good Laboratory Practice for Nonclinical Laboratory Studies
• [21 CFR Part 11] Electronic Records and Electronic Signatures
For further information on US FDA GLP Regulations, click here: www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm